Navigation Links
Brookdale Announces First Quarter 2008 Results
Date:5/7/2008

$(55,093) $(35,140)

Minority interest - 131

Benefit for income taxes (29,887) (20,568)

Equity in loss of unconsolidated ventures 173 1,453

Loss on extinguishment of debt 2,821 -

Interest expense:

Debt 28,987 25,239

Capitalized lease obligation 6,884 8,213

Amortization of deferred financing costs 1,557 1,618

Change in fair value of

derivatives and amortization 45,633 4,781

Interest income (1,626) (1,820)

Loss from operations (551) (16,093)

Depreciation and amortization 71,940 72,984

Facility lease expense 67,812 68,481

General and administrative (including

non-cash stock compensation expense) 36,388 40,653

Amortization of entrance fees(1) (6,691) (4,259)

Management fees (1,813) (1,496)

Facility Operating Income $167,085 $160,270

(1) Entrance fee sales, net of refunds paid, provided $2.6 million and

$1.9 million of cash for the three months ended March 31, 2008 and

2007, respectively.

Operating Data

The same store data, which includes for the twelve month period the effect of the historical results of the ARC facilities, for the three and twelve months ended March 31, 2008 and 2007 (in thousands) is presented below:

Three months ended March 31,

2008
'/>"/>

SOURCE Brookdale Senior Living Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine news :

1. Brookdale Announces Third Quarter Common Stock Dividend of $0.50
2. Brookdale Announces Third Quarter 2007 Release and Earnings Call
3. Brookdale Announces Third Quarter 2007 Results
4. Brookdale Senior Living Announces Enhanced Web Site
5. Brookdale Announces Fourth Quarter Common Stock Dividend of $0.50
6. Brookdale Senior Living Announces Changes in Senior Management and Board of Directors
7. Brookdale Announces Fourth Quarter and Full Year 2007 Release and Earnings Call
8. Brookdale Announces Fourth Quarter and Full Year 2007 Results
9. Brookdale to Present at Citi Small & Mid-Cap Conference on March 17
10. Brookdale to Present at Lehman Global Healthcare Conference on March 19
11. Brookdale Board of Directors Authorizes $150 Million Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)... July 23 /PRNewswire-FirstCall/ - Cardiome Pharma ... it has entered into an,agreement with CR Intrinsi...CR Intrinsic Investors, LLC, an affiliate of S.A.C...rtible preferred shares for gross proceeds of,US$2...for general corporate,purposes, costs associated w...
(Date:7/23/2008)...DNA to create faster, smaller, and more powerful c...scrambling to develop successful ways to use genet...professor at Rensselaer Polytechnic Institute sugg...tations, all we have to do is literally look aroun...rk Changizi has begun to develop a technique to tu...
(Date:7/23/2008)...-USNewswire/ -- The Children,s,Hospital of Philade...ion,gift that will enable the opening of a new ped...is gift, made possible by Athena and Nicholas,Kara... in the history of,Children,s Hospital and will gi...communities convenient access to world-class pedia...
(Date:7/23/2008)... Times may be tough, but,Hollywood,s young stars l...a dazzling new smile to boost confidence. Cosmetic...ty clients beam in on success, citing his,experien...confidence they,need for stardom. In agreement is ...ge smile designed by Dr. Kosdon., MTV,s Rock The ...
Breaking Medicine News(10 mins):Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3Health News:Study suggests human visual system could make powerful computer 2Health News:Study suggests human visual system could make powerful computer 3Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 2Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 3Health News:Rock The Cradle's Bad Boy Landon Brown Owes His Irresistible New Smile to Dr. Michael Kosdon 2
...n often disabling condition that affects primarily...ted fatigue // that cannot be overcome with rest a... of the condition is unknown, and there are no dia...hat children who have sedentary behaviors are at i...
...n between the use of two of the most common medica... risk for // bone fractures. Beta-blockers are com...e heart failure, chest pain, and abnormal heart rh...e drugs to prevent a second attack. Diuretics are ...
...Wake Forest University Baptist Medical Center rese...r research in monkeys suggested //that the type of...t heart attack severity. At an annual meeting of...in Washington, D.C. today, Dr. J. Koudy Williams w...
...essive eye disease targeting the light-collecting ...orldwide and can cause // vision loss. Researchers...osa, the addition of docosahexaenoic acid to vitam...enefits, according to a recent study. Researchers ...
Other Medicine News:Health News:Hormone therapy may affect heart attack severity in women 2
(Date:7/22/2008)...y 22 /- Following a,thoroug...of Progen,Pharmaceuticals Limited (ASX: PGL; Nasda...the PI-88 phase 3 study in liver cancer. Progen co...sting portfolio of compounds and,the company will ...opportunities through Merger & Acquisition activit...
(Date:7/22/2008)...s Development Plan Completed Successfully, DUBLIN...n Corporation,plc (NASDAQ: AMRN ) today announced...he U.S. Food and Drug Administration (FDA) to disc...treatment of,hypertriglyceridemia. Following these... with AMR101 in hypertriglyceridemia., Dr. Declan...
(Date:7/22/2008)...tress the Importance to Patients of Passing a ... RICHMOND, Va., July 22 /-...ow-on biologics and biopharmaceuticals, today,anno...ill present at a,Congressional briefing on Friday,...or establishing an approval pathway for follow-on,...
(Date:7/22/2008)...ve Laser Lipolysis Technology in the European ...., July 22 /- Cynosure, Inc...cturer of a broad array of,light-based aesthetic t...k,for Smartlipo MPX(TM), the company,s high-powere...y fat and tighten skin through collagen,remodeling...
Breaking Medicine Technology:Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 2Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 3Immunotec Inc announces appointment of President 26 CEO James A Northrop 1219 1Immunotec Inc announces appointment of President 26 CEO James A Northrop 1219 2PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 500 1PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 500 2PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 500 3PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 500 4 242 7 million awarded for metastatic colon cancer research 771 1 242 7 million awarded for metastatic colon cancer research 771 2 242 7 million awarded for metastatic colon cancer research 771 3Nanoparticle exposures happen says expert 769 1Nanoparticle exposures happen says expert 769 2
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: